Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or pilimumab-triggered autoimmunity

Programmed cell death protein 1 (PD-1) inhibitors are a common treatment strategy for metastatic melanoma and other tumour entities. Clinical trials u…

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Gutzmer, Ralf (VerfasserIn) , Koop, Anika (VerfasserIn) , Meier, Friedegund (VerfasserIn) , Hassel, Jessica C. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 16 February 2017
In: European journal of cancer
Year: 2017, Jahrgang: 75, Pages: 24-32
ISSN:1879-0852
DOI:10.1016/j.ejca.2016.12.038
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1016/j.ejca.2016.12.038
Verlag, Volltext: https://www.sciencedirect.com/science/article/pii/S0959804917300576
Volltext
Verfasserangaben:Ralf Gutzmer, Anika Koop, Friedegund Meier, Jessica C. Hassel, Patrick Terheyden, Lisa Zimmer, Lucie Heinzerling, Selma Ugurel, Claudia Pfohler, Anja Gesierich, Elisabeth Livingstone, Imke Satzger, Katharina C. Kähler

MARC

LEADER 00000caa a2200000 c 4500
001 1580324975
003 DE-627
005 20240316100513.0
007 cr uuu---uuuuu
008 180823s2017 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.ejca.2016.12.038  |2 doi 
035 |a (DE-627)1580324975 
035 |a (DE-576)510324975 
035 |a (DE-599)BSZ510324975 
035 |a (OCoLC)1341017274 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Gutzmer, Ralf  |d 1968-  |e VerfasserIn  |0 (DE-588)113713371  |0 (DE-627)502213558  |0 (DE-576)289772095  |4 aut 
245 1 0 |a Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or pilimumab-triggered autoimmunity  |c Ralf Gutzmer, Anika Koop, Friedegund Meier, Jessica C. Hassel, Patrick Terheyden, Lisa Zimmer, Lucie Heinzerling, Selma Ugurel, Claudia Pfohler, Anja Gesierich, Elisabeth Livingstone, Imke Satzger, Katharina C. Kähler 
264 1 |c 16 February 2017 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 23.08.2018 
520 |a Programmed cell death protein 1 (PD-1) inhibitors are a common treatment strategy for metastatic melanoma and other tumour entities. Clinical trials u… 
700 1 |a Koop, Anika  |d 1985-  |e VerfasserIn  |0 (DE-588)1130807797  |0 (DE-627)885195590  |0 (DE-576)487018834  |4 aut 
700 1 |a Meier, Friedegund  |d 1960-  |e VerfasserIn  |0 (DE-588)124970184  |0 (DE-627)369238672  |0 (DE-576)294594825  |4 aut 
700 1 |a Hassel, Jessica C.  |d 1975-  |e VerfasserIn  |0 (DE-588)129790702  |0 (DE-627)480399069  |0 (DE-576)29783715X  |4 aut 
773 0 8 |i Enthalten in  |t European journal of cancer  |d Amsterdam [u.a.] : Elsevier, 1992  |g 75(2017), Seite 24-32  |w (DE-627)266883400  |w (DE-600)1468190-0  |w (DE-576)090954173  |x 1879-0852  |7 nnas  |a Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or pilimumab-triggered autoimmunity 
773 1 8 |g volume:75  |g year:2017  |g pages:24-32  |g extent:9  |a Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or pilimumab-triggered autoimmunity 
856 4 0 |u http://dx.doi.org/10.1016/j.ejca.2016.12.038  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S0959804917300576  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180823 
993 |a Article 
994 |a 2017 
998 |g 129790702  |a Hassel, Jessica C.  |m 129790702:Hassel, Jessica C.  |d 910000  |d 911300  |e 910000PH129790702  |e 911300PH129790702  |k 0/910000/  |k 1/910000/911300/  |p 4 
999 |a KXP-PPN1580324975  |e 3023005133 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedDisp":"16 February 2017","dateIssuedKey":"2017"}],"relHost":[{"title":[{"title_sort":"European journal of cancer","title":"European journal of cancer"}],"note":["Gesehen am 21.03.24","Ungezählte Beil.: Supplement"],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"origin":[{"dateIssuedKey":"1992","publisherPlace":"Amsterdam [u.a.] ; [Erscheinungsort nicht ermittelbar]","dateIssuedDisp":"1992-","publisher":"Elsevier ; Pergamon Press"}],"disp":"Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or pilimumab-triggered autoimmunityEuropean journal of cancer","recId":"266883400","part":{"extent":"9","text":"75(2017), Seite 24-32","volume":"75","year":"2017","pages":"24-32"},"id":{"issn":["1879-0852"],"eki":["266883400"],"zdb":["1468190-0"]},"pubHistory":["28.1992 -"],"titleAlt":[{"title":"EJC online"}],"corporate":[{"display":"European Organization for Research on Treatment of Cancer","role":"isb"},{"role":"isb","display":"European Association for Cancer Research"},{"display":"European School of Oncology","role":"isb"}]}],"person":[{"family":"Gutzmer","given":"Ralf","role":"aut","display":"Gutzmer, Ralf"},{"display":"Koop, Anika","role":"aut","given":"Anika","family":"Koop"},{"role":"aut","given":"Friedegund","family":"Meier","display":"Meier, Friedegund"},{"family":"Hassel","given":"Jessica C.","role":"aut","display":"Hassel, Jessica C."}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"note":["Gesehen am 23.08.2018"],"title":[{"title_sort":"Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or pilimumab-triggered autoimmunity","title":"Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or pilimumab-triggered autoimmunity"}],"physDesc":[{"extent":"9 S."}],"recId":"1580324975","name":{"displayForm":["Ralf Gutzmer, Anika Koop, Friedegund Meier, Jessica C. Hassel, Patrick Terheyden, Lisa Zimmer, Lucie Heinzerling, Selma Ugurel, Claudia Pfohler, Anja Gesierich, Elisabeth Livingstone, Imke Satzger, Katharina C. Kähler"]},"id":{"doi":["10.1016/j.ejca.2016.12.038"],"eki":["1580324975"]}} 
SRT |a GUTZMERRALPROGRAMMED1620